Who owns Regeneron Pharmaceuticals (REGN)? Superinvestor holders
10 superinvestors of the 157 tracked here hold Regeneron Pharmaceuticals (REGN) in their latest 13F filing, with $5.7B between them. Mason Hawkins gives it the most weight: 4.95% of the reported portfolio.
Key facts
- Superinvestors holding it
- 10 of 157
- Biggest holder
- Dodge & Cox team, $3.6B
- Largest weight
- Mason Hawkins, 4.95%of their portfolio
- Combined value
- $5.7B
- Bought last quarter
- 5
- Sold last quarter
- 5
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Mason HawkinsSoutheastern Asset Management (Longleaf) | 4.95% | $95M | 152.32K | ▲ Added 17% | +21.66K | Q2 2026 |
| 2 | Harry BurnSound Shore Management | 2.99% | $95.7M | 126.18K | ▼ Reduced 0.6% | −813 | Q3 2026 |
| 3 | Dodge & Cox teamDodge & Cox | 1.94% | $3.6B | 4.77M | ▼ Reduced 2.0% | −96.44K | Q3 2026 |
| 4 | John Overdeck and David Siegel (founders)Two Sigma Investments | 0.48% | $659.3M | 869.51K | ▲ Added 33% | +213.37K | Q3 2026 |
| 5 | Josef LakonishokLSV Asset Management | 0.35% | $186.6M | 246.13K | ▼ Reduced 2.8% | −7.06K | Q3 2026 |
| 6 | Jim Simons (1938–2024)Renaissance Technologies | 0.28% | $206.4M | 272.22K | ▲ Added 84% | +124K | Q3 2026 |
| 7 | Cliff AsnessAQR Capital Management | 0.25% | $702.2M | 1.13M | ▼ Reduced 8.5% | −104.88K | Q2 2026 |
| 8 | Joel GreenblattGotham Asset Management | 0.15% | $65.6M | 105.17K | ▲ Added 27% | +22.32K | Q2 2026 |
| 9 | Ray Dalio (founder)Bridgewater Associates | 0.13% | $32M | 51.33K | ▲ Added 126% | +28.61K | Q2 2026 |
| 10 | Jeremy Grantham (co-founder)GMO (Grantham, Mayo, Van Otterloo) | 0.12% | $53.9M | 71.08K | ▼ Reduced 4.2% | −3.12K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 6 | 6.36M | $4.8B | 2 | 4 |
| Q2 2026 | 157 | 9 | 7.42M | $4.6B | 6 | 4 |
| Q1 2026 | 157 | 8 | 7.12M | $5.5B | 4 | 7 |
| Q4 2025 | 157 | 13 | 7.73M | $6B | 9 | 4 |
| Q3 2025 | 157 | 13 | 7.88M | $4.4B | 9 | 5 |
| Q2 2025 | 157 | 10 | 6.53M | $3.4B | 7 | 4 |
| Q1 2025 | 156 | 9 | 3.74M | $2.4B | 9 | 0 |
| Q4 2024 | 156 | 7 | 3.38M | $2.4B | 4 | 5 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Dodge & Cox team | 4.77M | 4.87M | 4.46M | 4.6M | 4.55M | 3.83M | 2.32M | 2.32M |
| John Overdeck and David Siegel (founders) | 869.51K | 656.12K | 812.24K | 281.15K | 469.9K | 499.83K | 372.07K | — |
| Jim Simons (1938–2024) | 272.22K | — | — | — | 275.16K | — | — | 247.74K |
| Josef Lakonishok | 246.13K | 253.2K | 196.28K | 166.51K | — | — | — | — |
| Harry Burn | 126.18K | 126.99K | 150.96K | 175.89K | 115.03K | — | — | — |
| Jeremy Grantham (co-founder) | 71.08K | 74.2K | 55.35K | 56.7K | 61.47K | 65.28K | 83.33K | 62.98K |
| Cliff Asness | · | 1.13M | 1.23M | 995.71K | 721.35K | — | — | 207.09K |
| Mason Hawkins | · | 152.32K | 130.66K | 165.79K | 144.61K | 160.58K | 114.88K | — |
| Joel Greenblatt | · | 105.17K | 82.85K | 80.27K | 84.23K | — | 32.05K | — |
| Ray Dalio (founder) | · | 51.33K | — | 72.75K | 235.38K | 89.05K | — | — |
| Brandon Haley | · | — | — | 460.72K | 151.73K | — | — | — |
| Israel Englander | · | — | — | 379.77K | — | 338.83K | — | — |
| Steve Cohen | · | — | — | 262.53K | 201.5K | — | — | — |
| Robert Pitts | · | — | — | 35.2K | — | — | — | — |
| David Shaw (founder) | · | — | — | — | 861.59K | 777.47K | 578.89K | 500.23K |
| Cathie Wood | — | — | — | — | 12.14K | 12.61K | 13.69K | 13.19K |
| Ken Griffin | · | — | — | — | — | 680.51K | — | — |
| Paul Tudor Jones | · | — | — | — | — | 84.55K | 126.09K | 28.57K |
| Andreas Halvorsen | · | — | — | — | — | — | 97.74K | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own REGN?
In their latest 13F filings: Mason Hawkins (4.95% of the portfolio, $95M), Harry Burn (2.99% of the portfolio, $95.7M), Dodge & Cox team (1.94% of the portfolio, $3.6B), John Overdeck and David Siegel (founders) (0.48% of the portfolio, $659.3M), Josef Lakonishok (0.35% of the portfolio, $186.6M), Jim Simons (1938–2024) (0.28% of the portfolio, $206.4M), Cliff Asness (0.25% of the portfolio, $702.2M), Joel Greenblatt (0.15% of the portfolio, $65.6M), and 2 more.
Who bought REGN last quarter?
Mason Hawkins (added 17%), John Overdeck and David Siegel (founders) (added 33%), Jim Simons (1938–2024) (added 84%), Joel Greenblatt (added 27%), Ray Dalio (founder) (added 126%). “Last quarter” is each investor's latest reported quarter.
Who sold REGN last quarter?
Reduced: Harry Burn (0.6% fewer shares), Dodge & Cox team (2.0% fewer shares), Josef Lakonishok (2.8% fewer shares), Cliff Asness (8.5% fewer shares), Jeremy Grantham (co-founder) (4.2% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Regeneron Pharmaceuticals (REGN)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/REGN/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to REGN by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.